PPARs: Regulators and Translational Targets in the Lung.
作者信息
Reddy Raju C, Rehan Virender K, Roman Jesse, Sime Patricia J
机构信息
Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Emory University and Atlanta VA Medical Center, Atlanta, GA 30033, USA.
出版信息
PPAR Res. 2012;2012:342924. doi: 10.1155/2012/342924. Epub 2012 Nov 4.
Abstract
摘要
相似文献
1
PPARs: Regulators and Translational Targets in the Lung.过氧化物酶体增殖物激活受体：肺中的调节因子及转化靶点
PPAR Res. 2012;2012:342924. doi: 10.1155/2012/342924. Epub 2012 Nov 4.
2
Functional Regulation of PPARs through Post-Translational Modifications.PPARs 的翻译为过氧化物酶体增殖物激活受体（peroxisome proliferator-activated receptors），是一类配体激活的转录因子。因此，此句译文为：过氧化物酶体增殖物激活受体（PPARs）的功能调节通过翻译后修饰。
Int J Mol Sci. 2018 Jun 12;19(6):1738. doi: 10.3390/ijms19061738.
3
Peroxisome proliferator activated receptor ligands as regulators of airway inflammation and remodelling in chronic lung disease.过氧化物酶体增殖物激活受体配体作为慢性肺部疾病气道炎症和重塑的调节剂。
PPAR Res. 2007;2007:14983. doi: 10.1155/2007/14983.
4
PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation.中枢神经系统中的过氧化物酶体增殖物激活受体：在神经退行性变和神经炎症中的作用。
Biol Rev Camb Philos Soc. 2017 Nov;92(4):2046-2069. doi: 10.1111/brv.12320. Epub 2017 Feb 20.
5
PPARs-Orchestrated Metabolic Homeostasis in the Adipose Tissue.过氧化物酶体增殖物激活受体（PPARs）在脂肪组织中的代谢稳态调控。
Int J Mol Sci. 2021 Aug 20;22(16):8974. doi: 10.3390/ijms22168974.
6
The mechanisms of action of PPARs.过氧化物酶体增殖物激活受体（PPARs）的作用机制。
Annu Rev Med. 2002;53:409-35. doi: 10.1146/annurev.med.53.082901.104018.
7
Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.过氧化物酶体增殖物与过氧化物酶体增殖物激活受体（PPARs）作为脂质代谢的调节因子。
Biochimie. 1997 Feb-Mar;79(2-3):81-94. doi: 10.1016/s0300-9084(97)81496-4.
8
[Research progress on active ingredients of traditional Chinese medicines improved insulin resistance based on PPARs targets].基于PPARs靶点的中药活性成分改善胰岛素抵抗的研究进展
Zhongguo Zhong Yao Za Zhi. 2015 Nov;40(22):4355-8.
9
Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs) in diabetes, obesity and cancer.代谢组学在理解过氧化物酶体增殖物激活受体（PPARs）在糖尿病、肥胖症和癌症中的作用中的应用。
Genome Med. 2012 Apr 30;4(4):32. doi: 10.1186/gm331.
10
Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation.过氧化物酶体增殖物激活受体：转录活性的调节及其在炎症中的作用
J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):267-73. doi: 10.1016/s0960-0760(03)00214-0.
引用本文的文献
1
Bacterial membrane nanovesicles encapsulating prodrug assemblies combine chemical and immunological therapies for chronic bacterial infection.包裹前药组装体的细菌膜纳米囊泡结合化学疗法和免疫疗法用于慢性细菌感染。
Nat Commun. 2025 Jun 5;16(1):5246. doi: 10.1038/s41467-025-60570-2.
2
Lipid Deficiency Contributes to Impaired Alveolar Progenitor Cell Function in Aging and Idiopathic Pulmonary Fibrosis.脂质缺乏导致衰老和特发性肺纤维化中肺泡祖细胞功能受损。
Am J Respir Cell Mol Biol. 2024 Aug;71(2):242-253. doi: 10.1165/rcmb.2023-0290OC.
3
Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma.过氧化物酶体增殖物激活受体作为哮喘的治疗靶点
PPAR Res. 2020 Jan 14;2020:8906968. doi: 10.1155/2020/8906968. eCollection 2020.
4
PPARs: Key Regulators of Airway Inflammation and Potential Therapeutic Targets in Asthma.过氧化物酶体增殖物激活受体：气道炎症的关键调节因子及哮喘潜在治疗靶点
Nucl Receptor Res. 2018;5. doi: 10.11131/2018/101306. Epub 2017 Dec 11.
5
A Combination of the Aerosolized PPAR-γ Agonist Pioglitazone and a Synthetic Surfactant Protein B Peptide Mimic Prevents Hyperoxia-Induced Neonatal Lung Injury in Rats.雾化的过氧化物酶体增殖物激活受体γ（PPAR-γ）激动剂吡格列酮与合成表面活性蛋白B肽模拟物联合应用可预防高氧诱导的新生大鼠肺损伤。
Neonatology. 2018;113(4):296-304. doi: 10.1159/000486188. Epub 2018 Feb 9.
6
The lung alveolar lipofibroblast: an evolutionary strategy against neonatal hyperoxic lung injury.肺泡脂肪成纤维细胞：一种对抗新生儿高氧性肺损伤的进化策略。
Antioxid Redox Signal. 2014 Nov 1;21(13):1893-904. doi: 10.1089/ars.2013.5793. Epub 2014 Mar 12.
Zotero 插件